Biological Drugs Market Report

Global and Regional Biological Drugs Market Details Research Report 2021-2026

  • POSTDATE：Jun 24, 2021
  • PAGES：192
  • REPORT CODE：GMM716673
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Biological Drugs Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Biological Drugs market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Biological Drugs market.

    By Player:

    • Biogen

    • Merck

    • Eli Lilly

    • Shire

    • GlaxoSmithKline

    • Pfizer

    • F Hoffmann-La Roche

    • Abbott Laboratories

    • Novartis

    • Baxter

    • Johnson & Johnson

    • Bristol-Myers Squibb

    • Amgen

    By Type:

    • Therapeutic Protein

    • Monoclonal Antibody

    • Vaccine

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Others

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Biological Drugs Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Biological Drugs Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Biological Drugs Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Biological Drugs Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Biological Drugs Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Biological Drugs Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Biogen

      • 3.1.1 Biogen - Company Business Overview

      • 3.1.2 Biogen - Company Financial Performance

      • 3.1.3 Biogen - Company Financial Performance of Biological Drugs

      • 3.1.4 Biological Drugs Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Merck

      • 3.2.1 Merck - Company Business Overview

      • 3.2.2 Merck - Company Financial Performance

      • 3.2.3 Merck - Company Financial Performance of Biological Drugs

      • 3.2.4 Biological Drugs Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Eli Lilly

      • 3.3.1 Eli Lilly - Company Business Overview

      • 3.3.2 Eli Lilly - Company Financial Performance

      • 3.3.3 Eli Lilly - Company Financial Performance of Biological Drugs

      • 3.3.4 Biological Drugs Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Shire

      • 3.4.1 Shire - Company Business Overview

      • 3.4.2 Shire - Company Financial Performance

      • 3.4.3 Shire - Company Financial Performance of Biological Drugs

      • 3.4.4 Biological Drugs Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 GlaxoSmithKline

      • 3.5.1 GlaxoSmithKline - Company Business Overview

      • 3.5.2 GlaxoSmithKline - Company Financial Performance

      • 3.5.3 GlaxoSmithKline - Company Financial Performance of Biological Drugs

      • 3.5.4 Biological Drugs Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Pfizer

      • 3.6.1 Pfizer - Company Business Overview

      • 3.6.2 Pfizer - Company Financial Performance

      • 3.6.3 Pfizer - Company Financial Performance of Biological Drugs

      • 3.6.4 Biological Drugs Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 F Hoffmann-La Roche

      • 3.7.1 F Hoffmann-La Roche - Company Business Overview

      • 3.7.2 F Hoffmann-La Roche - Company Financial Performance

      • 3.7.3 F Hoffmann-La Roche - Company Financial Performance of Biological Drugs

      • 3.7.4 Biological Drugs Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Abbott Laboratories

      • 3.8.1 Abbott Laboratories - Company Business Overview

      • 3.8.2 Abbott Laboratories - Company Financial Performance

      • 3.8.3 Abbott Laboratories - Company Financial Performance of Biological Drugs

      • 3.8.4 Biological Drugs Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Novartis

      • 3.9.1 Novartis - Company Business Overview

      • 3.9.2 Novartis - Company Financial Performance

      • 3.9.3 Novartis - Company Financial Performance of Biological Drugs

      • 3.9.4 Biological Drugs Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Baxter

      • 3.10.1 Baxter - Company Business Overview

      • 3.10.2 Baxter - Company Financial Performance

      • 3.10.3 Baxter - Company Financial Performance of Biological Drugs

      • 3.10.4 Biological Drugs Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Johnson & Johnson

      • 3.11.1 Johnson & Johnson - Company Business Overview

      • 3.11.2 Johnson & Johnson - Company Financial Performance

      • 3.11.3 Johnson & Johnson - Company Financial Performance of Biological Drugs

      • 3.11.4 Biological Drugs Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Bristol-Myers Squibb

      • 3.12.1 Bristol-Myers Squibb - Company Business Overview

      • 3.12.2 Bristol-Myers Squibb - Company Financial Performance

      • 3.12.3 Bristol-Myers Squibb - Company Financial Performance of Biological Drugs

      • 3.12.4 Biological Drugs Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Amgen

      • 3.13.1 Amgen - Company Business Overview

      • 3.13.2 Amgen - Company Financial Performance

      • 3.13.3 Amgen - Company Financial Performance of Biological Drugs

      • 3.13.4 Biological Drugs Product Benchmarking

      • 3.13.5 Strategic Initiatives

    4 Global Biological Drugs Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Biological Drugs Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Therapeutic Protein 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Monoclonal Antibody 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Vaccine 2016-2021

    • 4.3 Global Biological Drugs Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Therapeutic Protein 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Monoclonal Antibody 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Vaccine 2016-2021

    • 4.4 Global Biological Drugs Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Biological Drugs Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Biological Drugs Market Price By Type from 2016 to 2026

    5 Global Biological Drugs Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Biological Drugs

    • 5.2 Global Biological Drugs Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hospitals 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Ambulatory Surgical Centers 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Others 2016-2021

    • 5.3 Global Biological Drugs Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hospitals 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Ambulatory Surgical Centers 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Others 2016-2021

    • 5.4 Global Biological Drugs Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Biological Drugs Market Sales and Market Share by Application (Forecast)

    6 Global Biological Drugs Market Segment Analysis (Geography Level)

    • 6.1 Global Biological Drugs Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Biological Drugs Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Biological Drugs Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Biological Drugs Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Biological Drugs Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Biological Drugs Market from 2016 to 2020

    7. North America Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Biological Drugs Market Segment by Countries

      • 7.1.1 North America Biological Drugs Market Revenue Segment by Countries

      • 7.1.2 North America Biological Drugs Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Biological Drugs Market Segment (Product Type Level)

    • 7.3 North America Biological Drugs Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Biological Drugs Market Segment by Countries

      • 8.1.1 Europe Biological Drugs Market Revenue Segment by Countries

      • 8.1.2 Europe Biological Drugs Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Biological Drugs Market Segment (Product Type Level)

    • 8.3 Europe Biological Drugs Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Biological Drugs Market Segment by Countries

      • 9.1.1 Asia Biological Drugs Market Revenue Segment by Countries

      • 9.1.2 Asia Biological Drugs Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Biological Drugs Market Segment (Product Type Level)

    • 9.3 Asia Biological Drugs Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Biological Drugs Market Segment by Countries

      • 10.1.1 South America Biological Drugs Market Revenue Segment by Countries

      • 10.1.2 South America Biological Drugs Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Biological Drugs Market Segment (Product Type Level)

    • 10.3 South America Biological Drugs Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Biological Drugs Market Segment by Countries

      • 11.1.1 Middle East Biological Drugs Market Revenue Segment by Countries

      • 11.1.2 Middle East Biological Drugs Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Biological Drugs Market Segment (Product Type Level)

    • 11.3 Middle East Biological Drugs Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Biological Drugs Market Segment by Countries

      • 12.1.1 Africa Biological Drugs Market Revenue Segment by Countries

      • 12.1.2 Africa Biological Drugs Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Biological Drugs Market Segment (Product Type Level)

    • 12.3 Africa Biological Drugs Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Biological Drugs Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Biological Drugs Market Segment by Countries

      • 13.1.1 Oceania Biological Drugs Market Revenue Segment by Countries

      • 13.1.2 Oceania Biological Drugs Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Biological Drugs Market Segment (Product Type Level)

    • 13.3 Oceania Biological Drugs Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Biological Drugs Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Biological Drugs

      • 14.2.2 Manufacturing Process Analysis of Biological Drugs

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Biological Drugs Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Biological Drugs Industry Market Status, Pre-COVID-19

      • 15.5.3 Biological Drugs Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Biological Drugs Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Biological Drugs Product Picture

    • Table Biological Drugs Product Definition

    • Table Study Scope by Types

    • Figure Global Biological Drugs Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Biological Drugs Market Value by Application (2016 - 2026)

    • Figure Global Biological Drugs Market Size and Growth Rate from 2016 to 2026

    • Table Global Biological Drugs Production Capacity by Manufacturers (2016-2021)

    • Table Global Biological Drugs Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Biological Drugs Revenue by Manufacturers (2016-2021)

    • Table Global Biological Drugs Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Biological Drugs Plant Distribution and Sales Country

    • Table Biogen - Company Business Overview

    • Figure Biogen Total Revenue from 2018 to 2020

    • Table Biogen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Biogen Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Biological Drugs Product Benchmarking

    • Table Merck - Company Business Overview

    • Figure Merck Total Revenue from 2018 to 2020

    • Table Merck Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Merck Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Merck

    • Table Biological Drugs Product Benchmarking

    • Table Eli Lilly - Company Business Overview

    • Figure Eli Lilly Total Revenue from 2018 to 2020

    • Table Eli Lilly Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Biological Drugs Product Benchmarking

    • Table Shire - Company Business Overview

    • Figure Shire Total Revenue from 2018 to 2020

    • Table Shire Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Shire Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Shire

    • Table Biological Drugs Product Benchmarking

    • Table GlaxoSmithKline - Company Business Overview

    • Figure GlaxoSmithKline Total Revenue from 2018 to 2020

    • Table GlaxoSmithKline Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GlaxoSmithKline Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Biological Drugs Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Biological Drugs Product Benchmarking

    • Table F Hoffmann-La Roche - Company Business Overview

    • Figure F Hoffmann-La Roche Total Revenue from 2018 to 2020

    • Table F Hoffmann-La Roche Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure F Hoffmann-La Roche Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Biological Drugs Product Benchmarking

    • Table Abbott Laboratories - Company Business Overview

    • Figure Abbott Laboratories Total Revenue from 2018 to 2020

    • Table Abbott Laboratories Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Abbott Laboratories Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Biological Drugs Product Benchmarking

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Biological Drugs Product Benchmarking

    • Table Baxter - Company Business Overview

    • Figure Baxter Total Revenue from 2018 to 2020

    • Table Baxter Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Baxter Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Biological Drugs Product Benchmarking

    • Table Johnson & Johnson - Company Business Overview

    • Figure Johnson & Johnson Total Revenue from 2018 to 2020

    • Table Johnson & Johnson Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Johnson & Johnson Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Biological Drugs Product Benchmarking

    • Table Bristol-Myers Squibb - Company Business Overview

    • Figure Bristol-Myers Squibb Total Revenue from 2018 to 2020

    • Table Bristol-Myers Squibb Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bristol-Myers Squibb Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Biological Drugs Product Benchmarking

    • Table Amgen - Company Business Overview

    • Figure Amgen Total Revenue from 2018 to 2020

    • Table Amgen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amgen Sales and Growth Rate Analysis of Biological Drugs

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Biological Drugs Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Biological Drugs Market Revenue by Types (Historical)

    • Table Global Biological Drugs Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Therapeutic Protein 2016-2021

    • Figure Global Revenue and Growth Rate of Monoclonal Antibody 2016-2021

    • Figure Global Revenue and Growth Rate of Vaccine 2016-2021

    • Table Global Biological Drugs Market Sales by Types (Historical)

    • Table Global Biological Drugs Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Therapeutic Protein 2016-2021

    • Figure Global Sales and Growth Rate of Monoclonal Antibody 2016-2021

    • Figure Global Sales and Growth Rate of Vaccine 2016-2021

    • Table Global Biological Drugs Market Revenue by Types (Forecast)

    • Table Global Biological Drugs Market Revenue Market Share by Types (Forecast)

    • Table Global Biological Drugs Market Sales by Types (Forecast)

    • Table Global Biological Drugs Market Sales Market Share by Types (Forecast)

    • Figure Global Biological Drugs Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Biological Drugs

    • Table Global Biological Drugs Market Revenue by Application (Historical)

    • Table Global Biological Drugs Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hospitals 2016-2021

    • Figure Global Revenue and Growth Rate of Ambulatory Surgical Centers 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Biological Drugs Market Sales by Application (Historical)

    • Table Global Biological Drugs Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hospitals 2016-2021

    • Figure Global Sales and Growth Rate of Ambulatory Surgical Centers 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Biological Drugs Market Revenue by Application (Forecast)

    • Table Global Biological Drugs Market Revenue Market Share by Application (Forecast)

    • Table Global Biological Drugs Market Sales by Application (Forecast)

    • Table Global Biological Drugs Market Sales Market Share by Application (Forecast)

    • Table Global Biological Drugs Market Revenue by Geography (Historical)

    • Table Global Biological Drugs Market Revenue Market Share by Geography (Historical)

    • Figure Global Biological Drugs Revenue Market Share by Geography in 2020

    • Table Global Biological Drugs Market Sales by Geography (Historical)

    • Table Global Biological Drugs Market Sales Market Share by Geography (Historical)

    • Figure Global Biological Drugs Sales Market Share by Geography in 2020

    • Table Global Biological Drugs Market Revenue by Geography (Forecast)

    • Table Global Biological Drugs Market Revenue Market Share by Geography (Forecast)

    • Table Global Biological Drugs Market Sales by Geography (Forecast)

    • Table Global Biological Drugs Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Biological Drugs Revenue by Countries from 2016 to 2026

    • Table North America Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table North America Biological Drugs Sales by Countries from 2016 to 2026

    • Table North America Biological Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure North America Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure USA Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure USA Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table North America Biological Drugs Sales by Types from 2016 to 2026

    • Table North America Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table North America Biological Drugs Value by Types from 2016 to 2026

    • Table North America Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table North America Biological Drugs Sales by Application from 2016 to 2026

    • Table North America Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table North America Biological Drugs Value by Application from 2016 to 2026

    • Table North America Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table Europe Biological Drugs Revenue by Countries from 2016 to 2026

    • Table Europe Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table Europe Biological Drugs Sales by Countries from 2016 to 2026

    • Table Europe Biological Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure Germany Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure France Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure France Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Biological Drugs Sales by Types from 2016 to 2026

    • Table Europe Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table Europe Biological Drugs Value by Types from 2016 to 2026

    • Table Europe Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table Europe Biological Drugs Sales by Application from 2016 to 2026

    • Table Europe Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table Europe Biological Drugs Value by Application from 2016 to 2026

    • Table Europe Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table Asia Biological Drugs Revenue by Countries from 2016 to 2026

    • Table Asia Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table Asia Biological Drugs Sales by Countries from 2016 to 2026

    • Table Asia Biological Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure China Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure China Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure India Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure India Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Biological Drugs Sales by Types from 2016 to 2026

    • Table Asia Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table Asia Biological Drugs Value by Types from 2016 to 2026

    • Table Asia Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table Asia Biological Drugs Sales by Application from 2016 to 2026

    • Table Asia Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table Asia Biological Drugs Value by Application from 2016 to 2026

    • Table Asia Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table South America Biological Drugs Revenue by Countries from 2016 to 2026

    • Table South America Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table South America Biological Drugs Sales by Countries from 2016 to 2026

    • Table South America Biological Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure South America Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure Brazil Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table South America Biological Drugs Sales by Types from 2016 to 2026

    • Table South America Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table South America Biological Drugs Value by Types from 2016 to 2026

    • Table South America Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table South America Biological Drugs Sales by Application from 2016 to 2026

    • Table South America Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table South America Biological Drugs Value by Application from 2016 to 2026

    • Table South America Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table Middle East Biological Drugs Revenue by Countries from 2016 to 2026

    • Table Middle East Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table Middle East Biological Drugs Sales by Countries from 2016 to 2026

    • Table Middle East Biological Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Biological Drugs Sales by Types from 2016 to 2026

    • Table Middle East Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table Middle East Biological Drugs Value by Types from 2016 to 2026

    • Table Middle East Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table Middle East Biological Drugs Sales by Application from 2016 to 2026

    • Table Middle East Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table Middle East Biological Drugs Value by Application from 2016 to 2026

    • Table Middle East Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table Africa Biological Drugs Revenue by Countries from 2016 to 2026

    • Table Africa Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table Africa Biological Drugs Sales by Countries from 2016 to 2026

    • Table Africa Biological Drugs Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure Nigeria Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Biological Drugs Sales by Types from 2016 to 2026

    • Table Africa Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table Africa Biological Drugs Value by Types from 2016 to 2026

    • Table Africa Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table Africa Biological Drugs Sales by Application from 2016 to 2026

    • Table Africa Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table Africa Biological Drugs Value by Application from 2016 to 2026

    • Table Africa Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table Oceania Biological Drugs Revenue by Countries from 2016 to 2026

    • Table Oceania Biological Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Biological Drugs Revenue Market Share by Major Countries in 2020

    • Table Oceania Biological Drugs Sales by Countries from 2016 to 2026

    • Table Oceania Biological Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Biological Drugs Sales Market Share by Major Countries in 2020

    • Figure Australia Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biological Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Biological Drugs Sales by Types from 2016 to 2026

    • Table Oceania Biological Drugs Sales Market Share by Types from 2016 to 2026

    • Table Oceania Biological Drugs Value by Types from 2016 to 2026

    • Table Oceania Biological Drugs Value Market Share by Types from 2016 to 2026

    • Table Oceania Biological Drugs Sales by Application from 2016 to 2026

    • Table Oceania Biological Drugs Sales Market Share by Application from 2016 to 2026

    • Table Oceania Biological Drugs Value by Application from 2016 to 2026

    • Table Oceania Biological Drugs Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Biological Drugs

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Biological Drugs with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US